Cargando…

Conversion surgery for initially unresectable extrahepatic biliary tract cancer

BACKGROUNDS/AIMS: Surgical resection is the only curative treatment for biliary tract cancers; however, most patients undergo palliative chemotherapy because they are contraindicated for surgery. Conversion surgery, a treatment strategy for downsizing chemotherapy and subsequent surgical resection,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oh, Moon Young, Kim, Hongbeom, Choi, Yoo Jin, Byun, Yoonhyeong, Han, Youngmin, Kang, Jae Seung, Sohn, Heeju, Lee, Jung Min, Kwon, Wooil, Jang, Jin-Young
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association of Hepato-Biliary-Pancreatic Surgery 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8382869/ https://www.ncbi.nlm.nih.gov/pubmed/34402435 http://dx.doi.org/10.14701/ahbps.2021.25.3.349

Ejemplares similares

Predictive Features of Malignancy in Branch Duct Type Intraductal Papillary Mucinous Neoplasm of the Pancreas: A Meta-Analysis
por: Kwon, Wooil, et al.
Publicado: (2020)

Chronological changes in epidemiologic features of patients with gallstones over the last 20 years in a single large-volume Korean center
por: Zhao, Jiyong, et al.
Publicado: (2019)

The Role of Location of Tumor in the Prognosis of the Pancreatic Cancer
por: Lee, Mirang, et al.
Publicado: (2020)

Comparison of oncologic outcomes of extrahepatic cholangiocarcinoma according to tumor location: perihilar cholangiocarcinoma versus distal bile duct cancer
por: Lee, Jung Min, et al.
Publicado: (2022)

Comparison of perioperative short-term outcomes and oncologic long-term outcomes between open and laparoscopic distal pancreatectomy in patients with pancreatic ductal adenocarcinoma
por: Lee, Jung Min, et al.
Publicado: (2021)

Changes in postoperative long-term nutritional status and quality of life after total pancreatectomy
por: Oh, Moon Young, et al.
Publicado: (2021)

Prognostic Value of Carcinoembryonic Antigen (CEA) and Carbohydrate Antigen 19-9 (CA 19-9) in Gallbladder Cancer; 65 IU/mL of CA 19-9 Is the New Cut-Off Value for Prognosis
por: Kim, Myongjin, et al.
Publicado: (2021)

Clinicoradiological features of resected serous cystic neoplasms according to morphological subtype and preoperative tentative diagnosis: can radiological characteristics distinguish serous cystic neoplasms from other lesions?
por: Kang, Jae Seung, et al.
Publicado: (2020)

Serum carcinoembryonic antigen and carbohydrate antigen 19-9 as preoperative diagnostic biomarkers of extrahepatic bile duct cancer
por: Kim, Hyeong Seok, et al.
Publicado: (2021)

Short- and long-term outcomes of pancreaticoduodenectomy in elderly patients with periampullary cancer
por: Kang, Jae Seung, et al.
Publicado: (2020)

Biomarker Panel for the Diagnosis of Pancreatic Ductal Adenocarcinoma
por: Kim, Hongbeom, et al.
Publicado: (2020)

In vivo study for the hemostatic efficacy and foreign body reaction of a new powder-type polysaccharide hemostatic agent
por: Byun, Yoonhyeong, et al.
Publicado: (2022)

The Optimal Cutoff Value of Tumor Markers for Prognosis Prediction in Ampullary Cancer
por: Lee, Seungho, et al.
Publicado: (2023)

The development and clinical efficacy of simulation training of open duct-to-mucosa pancreaticojejunostomy using pancreas and intestine silicone models
por: Kang, Jae Seung, et al.
Publicado: (2022)

Clinical meaning of the World Health Organization morphologic classification (flat vs. tumoral) of gallbladder intraepithelial neoplasm as a prognostic factor in gallbladder cancer
por: Kim, Hongbeom, et al.
Publicado: (2020)

Stool Elastase as an Independent Prognostic Factor in Patients with Pancreatic Head Cancer
por: Hwang, Honam, et al.
Publicado: (2022)

Impact of conversion surgery after chemotherapy in patients with initially unresectable and recurrent biliary tract cancer
por: Nakamura, Ikuo, et al.
Publicado: (2023)

Oncologic Benefits of Neoadjuvant Treatment versus Upfront Surgery in Borderline Resectable Pancreatic Cancer: A Systematic Review and Meta-Analysis
por: Jung, Hye-Sol, et al.
Publicado: (2022)

Comparison of Clinical Outcomes of Borderline Resectable Pancreatic Cancer According to the Neoadjuvant Chemo-Regimens: Gemcitabine versus FOLFIRINOX
por: Choi, Yoo Jin, et al.
Publicado: (2021)

Limits of serum carcinoembryonic antigen and carbohydrate antigen 19-9 as the diagnosis of gallbladder cancer
por: Kang, Jae Seung, et al.
Publicado: (2021)

Adjuvant Radio-chemotherapy for extrahepatic biliary tract cancers
por: Bonet Beltrán, Marta, et al.
Publicado: (2011)

Helicobacter species in cancers of the gallbladder and extrahepatic biliary tract
por: de Martel, C, et al.
Publicado: (2009)

Risk factors deteriorating severe exocrine pancreatic insufficiency measured by stool elastase after pancreatoduodenectomy and the risk factors for weight loss
por: Cho, Ara, et al.
Publicado: (2022)

Clinical features and survival outcome of locally advanced extrahepatic cholangiocarcinoma
por: Lee, Sang-Jae, et al.
Publicado: (2014)

Clinical characteristics of patients with malignancy and long-term outcomes of surgical treatment of patients with choledochal cyst
por: Han, Wung Sun, et al.
Publicado: (2021)

Correction to: Comprehensive proteome and phosphoproteome profiling shows negligible influence of RNAlater on protein abundance and phosphorylation
por: Bae, Jingi, et al.
Publicado: (2019)

Comprehensive proteome and phosphoproteome profiling shows negligible influence of RNAlater on protein abundance and phosphorylation
por: Bae, Jingi, et al.
Publicado: (2019)

Pathology of the pancreas, gallbladder, extrahepatic biliary tract, and ampullary region /
por: Lack, Ernest E.
Publicado: (2003)

Role of biliary tract cytology in the evaluation of extrahepatic cholestatic jaundice
por: Gupta, Mamta, et al.
Publicado: (2013)

Extrahepatic Biliary Schwannomas: A Case Report
por: Jung, Ji Heon, et al.
Publicado: (2007)

Establishment and drug screening of patient-derived extrahepatic biliary tract carcinoma organoids
por: Wang, Zhiwei, et al.
Publicado: (2021)

Can Surgical Resection of Metastatic Lesions Be Beneficial to Pancreatic Ductal Adenocarcinoma Patients with Isolated Lung Metastasis?
por: Yun, Won-Gun, et al.
Publicado: (2022)

CORRIGENDUM: Addition of data source: Diagnostic model for pancreatic cancer using a multi-biomarker panel
por: Choi, Yoo Jin, et al.
Publicado: (2021)

Diagnostic model for pancreatic cancer using a multi-biomarker panel
por: Choi, Yoo Jin, et al.
Publicado: (2021)

Oncologic outcomes according to the location and status of resection margin in pancreas head cancer: role of radiation therapy in R1 resection
por: Sohn, Hee Ju, et al.
Publicado: (2022)

Detection of Circulating Tumor Cells in Resectable Pancreatic Ductal Adenocarcinoma: A Prospective Evaluation as a Prognostic Marker
por: Song, Byeong Geun, et al.
Publicado: (2021)

Congenital anomalies of the gastrointestinal tract: the liver, extrahepatic biliary tree and pancreas
por: Ludwig, Kathrin, et al.
Publicado: (2022)

Acute abdomen with jaundice: A clue to extrahepatic biliary tract perforation
por: Kumar, Anjay, et al.
Publicado: (2022)

Clinical validation of the 2017 international consensus guidelines on intraductal papillary mucinous neoplasm of the pancreas
por: Kang, Jae Seung, et al.
Publicado: (2019)

Recent progress in the treatment for unresectable biliary tract cancer
por: Endo, Itaru
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dqla079k4p1c5huq37lgs3v6qd